Scottish patients’ suffering with a life-threatening lung condition can now be monitored in the comfort of their own home using wearables and cloud technology.
NHS Greater Glasgow and Clyde believes the trial will result in fewer hospital visits for COPD patients – which costs about £6,000 per admission.